Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Sep:120:103437.
doi: 10.1016/j.brat.2019.103437. Epub 2019 Jul 7.

Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial

Affiliations
Randomized Controlled Trial

Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial

David S Black et al. Behav Res Ther. 2019 Sep.

Abstract

In this study we test the efficacy of Moment-by-Moment in Women's Recovery (MMWR), a mindfulness-based intervention adapted to support women with substance use disorder (SUD) while in residential treatment. We use a parallel-group randomized controlled trial with a time-matched psychoeducation control to test MMWR effects on residential treatment retention. We used clinical staff-determined residential site discharge status and discharge date from the SUD treatment site record to determine retention. We tested for study group differences in retention defined as time to treatment non-completion without improvement (i.e., patient left treatment before completion of the treatment plan and made little or no progress toward achieving treatment goals based on clinical team determination), as well as differences in self-report of study intervention mechanisms of action (i.e., mindfulness, perceived stress, distress tolerance, emotion regulation, distress, affect, and drug and alcohol craving). The analytic timeframe for the survival analysis was from study intervention start date to 150 days later. The sample (N = 200) was female, majority amphetamine/methamphetamine users (76%), Hispanic (58%), with a history of incarceration (62%). By the 150-day analytic endpoint, the sample had 74 (37%) treatment Completers, 42 (21%) still In-residence, 26 (13%) Non-completers with satisfactory progress, and 58 (29%) Non-completers without satisfactory progress. Survival analysis of the intent-to-treat sample showed the risk of non-completion without improvement was lower in MMWR as compared to the control group (adjusted hazard ratio = 0.42, 95% CI: 0.16-1.08, p = .07). Both groups improved on select self-reported mechanism measure scores at immediate post-intervention, but only in the MMWR group did class attendance (dosage) have a large-size correlation with improved mindfulness (r = .61, p < .01), distress tolerance (r = 0.55, p < .01) and positive affect (r = 0.52, p < .01) scores. The hazard ratio for retention was of medium-to-large effect size, suggesting the clinical relevance of adding MMWR to an all-women's, ethnoracially diverse, SUD residential treatment center. An extended curriculum may be helpful considering the protective benefits of class attendance on psychological health indicators.

Keywords: Dropout; Mindfulness; Residential; Retention; Substance use disorder; Women.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: All authors declare that there are no conflicts of interest.

Figures

Figure 1.
Figure 1.. Trial CONSORT diagram
Note. NA = Neurobiology of Addiction active control condition; MMWR = Moment by Moment in Women’s Recovery; ITT = intent to treat. By design, women missing the first class introduction session were not enrolled in the study, as they were likely to have already left the treatment facility.
Figure 2.
Figure 2.. Residential treatment discharge status by group across 150 day period, N=200
Note. NC=Non-completer with (w) or without (w/o) satisfactory progress. Completer: patient completed the course of SUD residential treatment; In-residence: patient still at the residential treatment site at analytic endpoint (i.e., day 150); NC w/ progress: patient left treatment site before completion of the treatment plan and before achieving all treatment goals but are deemed by the clinical team as having made important progress toward their treatment goals and person demonstrated improved stability but require additional intensive treatment; NC w/o progress: patient did not complete treatment and the clinical team determines that they made little to no progress toward achieving treatment goals.

References

    1. Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010–1024. - PubMed
    1. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA : the journal of the American Medical Association. 2000;284(13):1689–1695. - PubMed
    1. Hser YI, Evans E, Huang D, Anglin DM. Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv. 2004;55(7):767–774. - PubMed
    1. Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive behaviors. 1997;11(4):294.
    1. Condelli WS, Koch MA, Fletcher B. Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus: The New Jersey Substance Abuse Treatment Campus, Seacaucus, NJ. J Subst Abuse Treat. 2000;18(4):395–407. - PubMed

Publication types